Table 3.
Correlation between parameters | Group 1 | Group 2 | Group 3 | |
---|---|---|---|---|
Serum fructosamine (μmol/l) and FBS (mg/dl) | r | 0.0749 | 0.6446 | 0.7644 |
p | 0.6053 | <0.0001 | <0.0001 | |
Serum fructosamine (μmol/l) and PP2BS (mg/dl) | r | −0.1174 | 0.5254 | 0.8142 |
p | 0.4168 | 0.0001 | <0.0001 | |
Serum glycated albumin (μmol/l) and FBS (mg/dl) | r | −0.1182 | 0.5085 | 0.7675 |
p | 0.9351 | 0.0002 | <0.0001 | |
Serum glycated albumin (μmol/l) and PP2BS (mg/dl) | r | −0.1785 | 0.3956 | 0.8023 |
p | 0.2149 | 0.0045 | <0.0001 | |
Serum glycated β-lipoprotein (μmol/l) and FBS (mg/dl) | r | 0.0186 | 0.3702 | 0.5915 |
p | 0.8979 | 0.0081 | <0.0001 | |
Serum glycated β-lipoprotein (μmol/l) and PP2BS (mg/dl) | r | −0.1802 | 0.4013 | 0.6240 |
p | 0.2105 | 0.0039 | <0.0001 | |
Serum glycated Albumin (μmol/l) and fructosamine (μmol/l) | r | 0.4896 | 0.9133 | 0.9491 |
p | 0.0003 | <0.0001 | <0.0001 | |
Serum glycated β-lipoprotein (μmol/l) and fructosamine (μmol/l) | r | 0.3626 | 0.3073 | 0.6661 |
p | 0.0097 | 0.0300 | <0.0001 | |
Serum glycated β-lipoprotein (μmol/l) and glycated albumin (μmol/l) | r | 0.2152 | 0.1323 | 0.5625 |
p | 0.1295 | 0.3549 | <0.0001 |
r = correlation coefficient, p = probability